Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025Blood

A patient-derived CRISPR platform reveals selective dependencies in Acute Myeloid Leukemia

View Full Paper
Ask AI
Bookmark
Share

Authors

ATAbderrahmane TagmountCVChris D. VulpeSPStanley Pounds

Discussion

Loading...

Member takes

Overview

CRISPR screening uncovers drug resistance and genetic targets in primary AML cells, suggesting chemotherapy strategies.

Key Points

  • Adherent AML cells showed distinct genetic dependencies and therapeutic targets linked to drug resistance, including EDNRA.
  • A custom CRISPR/Cas9 screen targeted 2,440 genes, utilizing primary cells from nine AML patients over 30 days.
  • Analysis revealed crucial genes like SOD1 and EDNRA, playing roles in disease progression and treatment response.
  • These findings may lead to enhanced therapeutic strategies for chemotherapy-resistant AML patients.

Cite This Study

Tagmount et al. (2025) studied this question.

synapsesocial.com/papers/69362f574fa91c937236da3ahttps://doi.org/10.1182/blood-2025-3504
View Full Paper
Ask AI
Bookmark
Share